Growth Metrics

Cellectis (CLLS) Liabilities from Discontinued Operations: 2014-2023

Historic Liabilities from Discontinued Operations for Cellectis (CLLS) over the last 2 years, with Sep 2023 value amounting to $8.4 million.

  • Cellectis' Liabilities from Discontinued Operations rose 166.60% to $8.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $8.4 million, marking a year-over-year increase of 166.60%. This contributed to the annual value of -$3.8 million for FY2014, which is 90.45% up from last year.
  • Per Cellectis' latest filing, its Expense - Real Estate stood at $340,000 for Q4 2022, which was up 308.92% from -$162,739 recorded in Q1 2022.
  • Cellectis' Expense - Real Estate's 5-year high stood at $1.3 million during Q4 2021, with a 5-year trough of -$162,739 in Q1 2022.
  • For the 2-year period, Cellectis' Liabilities from Discontinued Operations averaged around -$2.3 million, with its median value being -$5.6 million (2022).
  • Data for Cellectis' Liabilities from Discontinued Operations shows a peak YoY skyrocketed of 223.28% (in 2023) over the last 5 years.
  • Over the past 2 years, Cellectis' Liabilities from Discontinued Operations (Quarterly) stood at -$12.6 million in 2022, then soared by 166.60% to $8.4 million in 2023.
  • Its Expense - Real Estate stands at $340,000 for Q4 2022, versus -$162,739 for Q1 2022 and $1.3 million for Q4 2021.